Published 09-09-2009 Xenonics Awarded $2 Million IDIQ Contract by the U.S. Army CARLSBAD, CALIFORNIA -- September 9, 2009 -- XENONICS HOLDINGS, INC. (AMEX:XNN) announced today that it has been awarded an Indefinite Delivery, Indefinite Quantity (IDIQ) contract valued at up to $2 million over the next two years by the U.S. Army for the Company's NightHunter 3 high-intensity illumination systems and related accessories. An initial $366,000 purchase order was received under this contract and is expected to ship this month."We are proud to supply our NightHunter 3 Weapons Mount Tactical Package to the U.S. Army Rapid Equipping Force," said Alan Magerman, CEO of Xenonics. About Xenonics Xenonics Holdings, Inc. (AMEX:XNN) develops and produces advanced, lightweight and compact ultra-high-intensity illumination and low-light vision products for military, law enforcement, public safety, and commercial and private sector applications. Xenonics' NightHunter line of illumination products is used by every branch of the U.S. Armed Forces as well as law enforcement and security agencies. Its SuperVision high-definition night vision is designed for commercial and military applications. Employing patented technologies, Xenonics provides innovative solutions for customers who must see farther so they can do their jobs better and safer. Xenonics' products represent the next generation in small, high intensity, high efficiency illumination and low-light vision systems. Visit Xenonics on the web at www.xenonics.com. ForwardLooking Statements Except for the historical statements, statements in this release may constitute forwardlooking statements within the meaning of section 21E of the Securities Exchange Act of 1934. When used, the words "anticipates," "believes," "expects," "intends," "future," and other similar expressions identify forwardlooking statements. These forwardlooking statements reflect management's current views with respect to future events and financial performance and are subject to risks and uncertainties, and actual results may differ materially from the outcomes contained in any forwardlooking statement. Factors that could cause these forwardlooking statements to differ from actual results include delays in development, marketing or sales of new products, and other risks and uncertainties discussed in the company's periodic reports on Form 10K and 10Q and other filings with the Securities and Exchange Commission. Xenonics Holdings undertakes no obligation to update or revise any forwardlooking statements. Download PDF > |
